Improving tumor budding reporting in colorectal cancer: a Delphi consensus study

Autor: Kieran Sheahan, Tine Plato Kuhlmann, John-Melle Bokhorst, Sanjay Kakar, Iris D. Nagtegaal, Jeroen van der Laak, Miriam Cuatrecasas, Inti Zlobec, Richard Kirsch, Robert H. Riddell, Susan Aherne, Ari Ristimäki, Valeria Barresi, Alessandro Lugli, Hala El-Zimaity, Jean-François Fléjou, David Gibbons, Darren Treanor, Michael Vieth, Scarlet Brockmoeller, Gieri Cathomas, Benoit Terris, Maurice B Loughrey, Tariq Sami Haddad, Cord Langner, Femke Simmer
Přispěvatelé: Department of Pathology, HUSLAB, University of Helsinki, Helsinki University Hospital Area, Radboud University Medical Center [Nijmegen], University of Bern, St Vincent's University Hospital, University College Dublin [Dublin] (UCD), University of Verona (UNIVR), Hôpital Cochin [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), University of Leeds, Barcelona Centre for International Health Research, Hospital Clinic (CRESIB), Universitat de Barcelona (UB), CHU Saint-Antoine [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Kantonsspital Baselland [Bruderholz] (KSBL), Mt. Sinai Hospital [Toronto, Canada], Herlev and Gentofte Hospital, University of Graz, Queen's University [Belfast] (QUB), University of California, Linköping University (LIU), University of Bayreuth, Karl-Franzens-Universität [Graz, Autriche]
Rok vydání: 2021
Předmět:
Delphi Technique
Colorectal cancer
Biopsy
Delphi method
Modified delphi
Tumor budding
0302 clinical medicine
Cell Movement
Tumours of the digestive tract Radboud Institute for Molecular Life Sciences [Radboudumc 14]
computer.programming_language
0303 health sciences
Pathology
Clinical

Consensus conference
Gastrointestinal pathology
Cell Differentiation
General Medicine
3. Good health
Women's cancers Radboud Institute for Health Sciences [Radboudumc 17]
ITBCC
030220 oncology & carcinogenesis
Original Article
Colorectal Neoplasms
medicine.medical_specialty
Consensus
education
Colonic Polyps
610 Medicine & health
Pathology and Forensic Medicine
03 medical and health sciences
Predictive Value of Tests
medicine
Humans
Neoplasm Invasiveness
Molecular Biology
030304 developmental biology
Neoplasm Staging
Cancer och onkologi
Carcinoma
Cancer
Cell Biology
medicine.disease
Delphi study
Cancer and Oncology
Family medicine
570 Life sciences
biology
3111 Biomedicine
computer
Delphi
[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
Zdroj: Virchows Archiv, 479, 3, pp. 459-469
Virchows Archiv
Virchows Archiv, Springer Verlag, 2021, 479 (3), pp.459-469. ⟨10.1007/s00428-021-03059-9⟩
Haddad, T S, Lugli, A, Aherne, S, Barresi, V, Terris, B, Bokhorst, J M, Brockmoeller, S F, Cuatrecasas, M, Simmer, F, El-Zimaity, H, Fléjou, J F, Gibbons, D, Cathomas, G, Kirsch, R, Kuhlmann, T P, Langner, C, Loughrey, M B, Riddell, R, Ristimäki, A, Kakar, S, Sheahan, K, Treanor, D, van der Laak, J, Vieth, M, Zlobec, I & Nagtegaal, I D 2021, ' Improving tumor budding reporting in colorectal cancer : a Delphi consensus study ', Virchows Archiv, vol. 479, no. 3, pp. 459-469 . https://doi.org/10.1007/s00428-021-03059-9
Haddad, Tariq Sami; Lugli, Alessandro; Aherne, Susan; Barresi, Valeria; Terris, Benoît; Bokhorst, John-Melle; Brockmoeller, Scarlet Fiona; Cuatrecasas, Miriam; Simmer, Femke; El-Zimaity, Hala; Fléjou, Jean-François; Gibbons, David; Cathomas, Gieri; Kirsch, Richard; Kuhlmann, Tine Plato; Langner, Cord; Loughrey, Maurice B; Riddell, Robert; Ristimäki, Ari; Kakar, Sanjay; ... (2021). Improving tumor budding reporting in colorectal cancer: a Delphi consensus study. Virchows Archiv, 479(3), pp. 459-469. Springer 10.1007/s00428-021-03059-9
Virchows Archiv, 479, 459-469
ISSN: 0945-6317
1432-2307
Popis: Tumor budding is a long-established independent adverse prognostic marker in colorectal cancer, yet methods for its assessment have varied widely. In an effort to standardize its reporting, a group of experts met in Bern, Switzerland, in 2016 to reach consensus on a single, international, evidence-based method for tumor budding assessment and reporting (International Tumor Budding Consensus Conference [ITBCC]). Tumor budding assessment using the ITBCC criteria has been validated in large cohorts of cancer patients and incorporated into several international colorectal cancer pathology and clinical guidelines. With the wider reporting of tumor budding, new issues have emerged that require further clarification. To better inform researchers and health-care professionals on these issues, an international group of experts in gastrointestinal pathology participated in a modified Delphi process to generate consensus and highlight areas requiring further research. This effort serves to re-affirm the importance of tumor budding in colorectal cancer and support its continued use in routine clinical practice. Supplementary Information The online version contains supplementary material available at 10.1007/s00428-021-03059-9.
Databáze: OpenAIRE